Home page Home page

Sivextro
tedizolid phosphate

Package leaflet: Information for the patient


Sivextro 200 mg film-coated tablets

tedizolid phosphate


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Sivextro for examples.

Ask your doctor or pharmacist if you are not sure whether you are taking any of these medicines.


Diarrhoea

Contact your doctor straight away if you suffer from diarrhoea during or after your treatment. Do not take any medicine to treat your diarrhoea without first checking with your doctor.


Resistanceto antibiotics

Bacteria can become resistant to treatment with antibiotics over time. This is when antibiotics cannot stop the growth of bacteria and treat your infection. Your doctor will decide if you should be given Sivextro to treat your infection.


Possibleside effects

Certain side effects have been observed with Sivextro or another member of the oxazolidinone class when administered over a duration exceeding that recommended for Sivextro. Tell your doctor straight

away if you suffer from any of the following while taking Sivextro:

a low white blood cell count

anaemia (low red blood cells)

bleeding or bruising easily

loss of sensitivity in your hands or feet (such as numbness, prickling/tingling, or sharp pains)

any problems with your eyesight such as blurred vision, changes in colour vision, difficulty in

seeing detail or if your field of vision becomes restricted.


Children

This medicine should not be used in children under 12 years of age as it has not been studied enough in this population.


Other medicines and Sivextro

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important that you tell your doctor if you are also taking:

amitriptyline, citalopram, clomipramine, dosulepin, doxepin, fluoxetine, fluvoxamine,

imipramine, isocarboxazid, lofepramine, moclobemide, paroxetine, phenelzine, selegiline and sertraline (used to treat depression)

sumatriptan, zolmitriptan (used to treat migraine)

imatinib, lapatinib (used to treat cancer)

methotrexate (used to treat cancer, rheumatoid arthritis or psoriasis)

sulfasalazine (used to treat inflammatory bowel diseases)

topotecan (used to treat cancer)

statins such as pitavastatin, rosuvastatin (used to lower blood cholesterol)


Sivextro can interfere with the effects of these medicines. Your doctor will explain more.


Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


It is not known if Sivextro passes into breast milk in humans. Ask your doctor for advice before breast-feeding your baby.


Driving and using machines

Do not drive or use machines if you feel dizzy or tired after taking this medicine.

  1. How to take Sivextro


    Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


    The recommended dose is one 200 mg tablet once a day for 6 days. The tablets are swallowed whole and can be taken with or without food or drink.

    Talk to a doctor if you do not feel better, or if you feel worse after 6 days.


    If you take more Sivextro than you should

    Contact your doctor, pharmacist or nearest hospital casualty department as soon as possible if you have taken more tablets than you should, and take your medicine with you.


    If you forget to take Sivextro

    If you forget to take your medicine, take the dose as soon as possible anytime up to 8 hours prior to the next scheduled dose. If less than 8 hours remains before the next dose, then wait until the next scheduled dose. Do not take a double dose to make up for a forgotten dose. If in any doubt, contact your pharmacist for advice.


    You should take all 6 tablets to complete your course of treatment, even if you have missed a dose.


    If you stop taking Sivextro

    If you stop taking Sivextro without the advice of your doctor, your symptoms may get worse. Talk to your doctor or pharmacist before you stop taking your medicine.


    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


  2. Possible side ef ects


    Like all medicines, this medicine can cause side effects, although not everybody gets them.


    Contact your doctor straight away if you suffer from diarrhoea during or after your treatment.


    Other side ef ects may include:

    Common side effects (may affect up to 1 in 10 people)

    Nausea

    Vomiting

    Headache

    Itching all over the body

    Tiredness

    Dizziness


    Uncommon side effects (may affect up to 1 in 100 people)

    Fungal infections of skin, mouth and vagina (oral / vaginal thrush)

    Itching (including itching due to allergic reaction), hair loss, acne, red and/or itchy rash or hives,

    excessive sweating

    Decrease or loss of skin sensitivity, tingling/prickling skin sensation

    Hot flush or blushing/redness in the face, neck or upper chest

    Abscess (swollen, pus-filled lump)

    Vaginal infection, inflammation or itching

    Anxiety, irritability, shaking or trembling

    Respiratory tract (sinuses, throat and chest) infection

    Dryness in the nose, congestion in the chest, cough

    Sleepiness, abnormal sleep pattern, difficulty sleeping, nightmares (unpleasant/disturbing

    dreams)


    Dry mouth, constipation, indigestion, pain/discomfort in the belly (abdomen), retching, dry

    heaving, bright red blood in the stool

    Acid reflux disease (heartburn, pain or difficulty swallowing), flatulence/passing wind

    Joint pain, muscle spasms, back pain, neck pain, pain/discomfort in limbs, decrease of grip

    strength

    • Blurred vision, ‘floaters’ (small shapes seen floating in the field of vision)

    Swollen or enlarged lymph nodes

    Allergic reaction

    Dehydration

    Poor control of diabetes

    Abnormal sense of taste

    Slow heartbeat

    Fever

    Swelling in ankles and/or feet

    Abnormal smelling urine, abnormal blood tests


    Frequency not known (frequency cannot be estimated from the available data)

    Bleeding or bruising easily (due to low numbers of platelets, the small cells involved in clotting

    in your blood)


    Reporting of side ef ects

    image

    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the nationalreportingsystem listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


  3. How to store Sivextro


    Keep this medicine out of the sight and reach of children.


    Do not use this medicine after the expiry date which is stated on the carton or blister label after

    “EXP”. The expiry date refers to the last day of that month.


    This medicinal product does not require any special storage conditions.


    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  4. Contents of the pack and other information What Sivextro contains

The active substance is tedizolid phosphate. Each film-coated tablet contains 200 mg of

tedizolid phosphate.

The other ingredients are microcrystalline cellulose, mannitol, povidone, crospovidone and

magnesium stearate within the tablet core. The film coat of the tablet contains polyvinyl alcohol, titanium dioxide (E171), macrogol, talc and yellow iron oxide (E172).


What Sivextro looks like and contents of the pack

Sivextro is an oval, yellow film-coated tablet imprinted with ‘TZD’ on one side and ‘200’ on the other

side.


It is available in 6 × 1 tablets in perforated unit-dose blisters.

Marketing Authorisation Holder and Manufacturer

Merck Sharp & Dohme B.V. Waarderweg 39

2031 BN Haarlem The Netherlands


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien

MSD Belgium

Tél/Tel: +32(0)27766211

dpoc_belux@merck.com

Lietuva

UAB Merck Sharp & Dohme Tel.: +370 5 278 02 47

msd_lietuva@merck.com


България

Мерк Шарп и Доум България ЕООД

Тел.: +359 2 819 3737

info-msdbg@merck.com


Luxembourg/Luxemburg

MSD Belgium

Tél/Tel: +32(0)27766211

dpoc_belux@merck.com


Česká republika

Merck Sharp & Dohme s.r.o. Tel.: +420 233 010 111

dpoc_czechslovak@merck.com


Magyarország

MSD Pharma Hungary Kft. Tel.: +361 888 53 00

hungary_msd@merck.com


Danmark

MSD Danmark ApS Tlf: +45 4482 4000

dkmail@merck.com

Malta

Merck Sharp & Dohme Cyprus Limited Tel: 8007 4433 (+356 99917558)

malta_info@merck.com


Deutschland

MSD Sharp & Dohme GmbH

Tel: 0800 673 673 673 (+49 (0) 89 4561 0)

e-mail@msd.de

Nederland

Merck Sharp & Dohme B.V.

Tel: 0800 9999000 (+31 23 5153153)

medicalinfo.nl@merck.com


Eesti

Merck Sharp & Dohme OÜ Tel.: +372 6144 200

msdeesti@merck.com

Norge

MSD (Norge) AS Tlf: +47 32 20 73 00

msdnorge@msd.no


Ελλάδα

MSD Α.Φ.Β.Ε.Ε.

Τηλ: +30 210 98 97 300

dpoc_greece@merck.com


Österreich

Merck Sharp & Dohme Ges.m.b.H.

Tel: +43 (0) 1 26 044

msd-medizin@merck.com


España

Merck Sharp & Dohme de España, S.A. Tel: +34 91 321 06 00

msd_info@merck.com

Polska

MSD Polska Sp.z o.o. Tel.: +48 22 549 51 00

msdpolska@merck.com


France

MSD France

Tél: + 33 (0) 1 80 46 40 40

Portugal

Merck Sharp & Dohme, Lda Tel: +351 21 4465700

inform_pt@merck.com

Hrvatska

Merck Sharp & Dohme d.o.o. Tel: + 385 1 6611 333

croatia_info@merck.com

România

Merck Sharp & Dohme Romania S.R.L. Tel: +40 21 529 29 00

msdromania@merck.com


Ireland

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 299 8700

medinfo_ireland@merck.com

Slovenija

Merck Sharp & Dohme, inovativna zdravila d.o.o.

Tel: + 386 1 5204 201

msd.slovenia@merck.com


Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

Merck Sharp & Dohme, s. r. o. Tel.: +421 2 58282010

dpoc_czechslovak@merck.com


Ιtalia

MSD Italia S.r.l.

Tel: +39 06 361911

medicalinformation.it@merck.com


Suomi/Finland

MSD Finland Oy

Puh/Tel: +358 (0) 9 804650

info@msd.fi


Κύπρος

Merck Sharp & Dohme Cyprus Limited

Τηλ: 800 00 673 (+357 22866700)

cyprus_info@merck.com


Sverige

Merck Sharp & Dohme (Sweden) AB Tel: +46 77 5700488

medicinskinfo@merck.com


Latvija

SIA Merck Sharp & Dohme Latvija Tel: +371 67364224

msd_lv@merck.com.

United Kingdom (Northern Ireland)

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 2998700

medinfoNI@msd.com


This leaflet was last revised in {MM/YYYY}.


.